Edition:
United States

Beijing Tiantan Biological Products Corp Ltd (600161.SS)

600161.SS on Shanghai Stock Exchange

25.61CNY
1:59am EST
Change (% chg)

¥0.47 (+1.87%)
Prev Close
¥25.14
Open
¥25.40
Day's High
¥25.67
Day's Low
¥25.00
Volume
3,206,369
Avg. Vol
7,729,634
52-wk High
¥39.60
52-wk Low
¥23.85

Chart for

About

BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED is a China-based company principally engaged in the biopharmaceutical businesses. The Company’s primary products include preventive products, blood products and other biological products, such as the influenza A (H1N1) vaccines (split, inactivated),hepatitis B vaccines,... (more)
No analyst recommendations are available for .

Overall

Beta: 0.72
Market Cap(Mil.): ¥16,846.49
Shares Outstanding(Mil.): 670.11
Dividend: 0.23
Yield (%): 0.92

Financials

  Industry Sector
P/E (TTM): -- 32.23 16.73
EPS (TTM): -- -- --
ROI: -- 14.02 35.60
ROE: -- 15.49 17.23

BRIEF-Beijing Tiantan Biological Products unit buys three blood products firms

Jan 19Beijing Tiantan Biological Products Corp Ltd

Jan 19 2018

BRIEF-Beijing Tiantan Biological Products' Controlling Shareholder To Increase Holdings

Dec 19 Beijing Tiantan Biological Products Corp Ltd:

Dec 19 2017

BRIEF-Beijing Tiantan Biological Products' share trade to resume after amending acquisition plan

Dec 13 Beijing Tiantan Biological Products Corp Ltd:

Dec 13 2017

BRIEF-Beijing Tiantan Biological Products' unit to buy stakes in 3 firms for 2.7 bln yuan

Dec 1 Beijing Tiantan Biological Products Corp Ltd:

Dec 01 2017

BRIEF-Beijing Tiantan Biological Products' share trade to halt pending announcement

Oct 16 Beijing Tiantan Biological Products Corp Ltd

Oct 16 2017

BRIEF-Beijing Tiantan Biological Products sees 9-month net profit rise 483 pct y/y

Oct 10 Beijing Tiantan Biological Products Corp Ltd

Oct 10 2017

Earnings vs. Estimates